Skip to main content
Home
  • Get Care
    • Find a Doctor
    • Request an Appointment
    • Virtual Visits
    • Locations & Directions
    • News
    • About Columbia Surgery
    • All Resources
  • Surgical Specialties
      • Adrenal
      • Aorta
      • Breast
      • Colorectal
      • Colorectal (Global Center)
      • Esophageal
      • Gall Bladder & Appendix
      • Gastric Cancer
      • Heart (Adult)
      • Heart (Pediatric)
      • Hernia
      • Kidney/Pancreas Transplantation
      • Liver Transplantation
      • Lung & Chest
      • Melanoma
      • Pancreas
      • Parathyroid
      • Pediatric/Neonatal
      • Plastic & Reconstructive
      • Robotic Surgery
      • Sarcoma
      • Thyroid
      • Vascular
      • Weight Loss Surgery
    • All Specialties
  • Research & Trials
    • About Research
    • About Clinical Trials
    • Basic & Translational Research
    • Cardiovascular Research
    • Clinical Research
    • Innovation & Outcomes Research
    • Translational Immunology Research
    • Transplant Research
    • All Research & Trials
  • Conditions & Treatments
      • Adrenal
      • Aortic
      • Breast
      • Colorectal
      • Esophageal
      • Gallbladder & Appendix (General Surgery)
      • Heart (Adult)
      • Hernia
      • Kidney
      • Liver
      • Lung & Chest (Thoracic)
      • Pancreas
      • Parathyroid
      • Pediatric (Neonatal)
      • Plastics (Cosmetic & Reconstructive)
      • Skin
      • Stomach (Gastric)
      • Thyroid
      • Vascular
      • Weight Loss (Bariatric)
    • All Conditions and Treatments
  • For Students and Professionals
  • Ways to Help
  • Request an Appointment

Search results

Phase I Window of Opportunity Study of Parasympathetic Stimulation with Bethanechol in Localized Pancreatic Adenocarcinoma Prior to Surgery

… Phase I Window of Opportunity Study of Parasympathetic Stimulation with Bethanechol in Localized …

Last Modified: 02/13/2023 - 21:07

A Phase Ib/2, Multicenter, Open-label Trial to Evaluate the Safety and Efficacy of Talimogene Laherparepvec and Ipilimumab Compared to Ipilimumab Alone in Subjects with Previously Untreated, Unresected, Stage IIIB-IV Melanoma

… The purpose of this study is to find out more about talimogene … tumor is not removable by surgery or has spread to other parts of the body. The study will be conducted in two parts. … on which part of the study they will participate in, how their disease responds to study drugs, or how their body …

Last Modified: 02/13/2023 - 21:06

Which Diagnostic Tests are Commonly Performed in the Evaluation Process?

… will be many blood tests. One is performed to determine the presence of the HIV antibody; we will require your consent and results … and any complicating conditions that may exist in other parts of your body. Sometimes we discover conditions that … Which Diagnostic Tests are Commonly Performed in the Evaluation Process? …

Last Modified: 01/15/2026 - 15:51

Columbia Lung and Esophageal Center of New Jersey

… The region's best lung doctors are now nearby. Pulmonologists … Sarcoidosis treatments (We are a designated Center of Excellence by WASOG ) Lung transplant evaluation Pectus … from the comfort of your own home. You’ll receive the same quality care you’ve come to expect from an in-person visit, …

Last Modified: 08/12/2025 - 11:11

The LESS GERD Trial For Adults Living with Severe Reflux

… disease that affects nearly 65 million people in the United States. 1 It occurs when stomach acid or … (esophagus). The backwash (reflux) irritates the lining of your esophagus and causes GERD. 2 Frequent and troublesome … and regurgitation); and effect of GERD on overall quality of life. Visit www.lessgerd.com for more information …

Last Modified: 02/13/2023 - 21:07

A Multi-Center, Randomized, Prospective, Open-Label Phase III Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Hepatitis C Immune Globulin Intravenous (Human), Civacir, in Orthotopic Liver Transplant Recipients

… The purpose of this study is to test the safety and efficacy of Civacir® to prevent the recurrence … Prospective, Open-Label Phase III Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Hepatitis C Immune Globulin Intravenous (Human), Civacir, …

Last Modified: 02/13/2023 - 21:06

A Phase 2 open-label study in patients with recurrent Genotype 1 hepAtitis C post orthotopic Liver transplAnt to eXplore the safety and efficacY of simeprevir and sofosbuvir with and without ribavirin

… The purpose of this study is to evaluate sustained virologic response 12 weeks after the end of treatment (SVR12) following 12 weeks of simeprevir … 1 hepAtitis C post orthotopic Liver transplAnt to eXplore the safety and efficacY of simeprevir and sofosbuvir with and …

Last Modified: 02/13/2023 - 21:06

The Heart-Growth Project: An Innovative Approach to Congenital Heart Disease

… David Kalfa, MD, PhD, has received a grant from the CHD Coalition to create and test a new type of heart valve that can grow and conform to the patient’s … need for multiple surgeries and greatly improving their quality of life. More than 40% of these patients require the …

Last Modified: 07/07/2025 - 15:56

CytoSorb Reduction of Free Hemoglobin During Cardiac Surgery

… To assess the impact of the CytoSorb device during cardiopulmonary bypass compared to standard of care without CytoSorb. Measures include change in plasma … CytoSorb Reduction of Free Hemoglobin During Cardiac Surgery …

Last Modified: 02/13/2023 - 21:07

The Wedding Goes On, Thanks to Columbia’s Mobile ECMO Team

… Groom-to-be Eric Long became sick the evening of his wedding rehearsal dinner, and by the next day, he was diagnosed with severe lung failure.  See … The Wedding Goes On, Thanks to Columbia’s Mobile ECMO Team …

Last Modified: 02/19/2023 - 13:10

Fixing the Gap in Breast Cancer Care in African American Communities

… MD Cancer is a major public health problem worldwide. In the United States, it is the second leading cause of death, and it is estimated that 39% of men and 27% of women will be diagnosed with invasive cancer in their lifetime - that’s more than one in three people. …

Last Modified: 02/23/2023 - 18:01

Naltrexone Implant a Powerful New Tool in the Fight Against Opioid Addiction

… like hydrocodone, oxycodone, heroin, and fentanyl do to the brain. Opioids work on the same reward receptors as … your brain changes after each use, it adapts; and feelings of euphoria dampen. Now, the opioid is creating new circuits, … at a moment when someone's really motivated to get over their addiction, they’ll be willing to come in and have a …

Last Modified: 02/23/2023 - 18:01

A Phase 3, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/GS-5816 Fixed-Dose Combination in Subjects with Chronic HCV Infection and Child-Pugh Class B Cirrhosis

… This study will evaluate the efficacy, safety, and tolerability of sofosbuvir (SOF)/GS-5816 fixed dose combination (FDC) with … A Phase 3, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/GS-5816 Fixed-Dose Combination in Subjects with …

Last Modified: 02/13/2023 - 21:06

Guest Blog: The Atlantic’s CEO Nick Thompson on Thyroid Cancer & Recovery

… Nick Thompson, CEO of The Atlantic and former editor-in-chief of WIRED, shares … oddly, solved a dilemma for me. All patients who have their thyroid removed because of cancer have to follow up the … Guest Blog: The Atlantic’s CEO Nick Thompson on Thyroid Cancer & Recovery …

Last Modified: 02/23/2023 - 18:02

Pagination

  • « First First page
  • ‹‹ Previous page
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • …
  • ›› Next page
  • Last » Last page

Footer About

  • About Us
  • Request an Appointment
  • Virtual Visits
  • Organ Donation
  • Contact Us
  • Subscribe To Our Newsletter

Footer About 2

  • Directory
  • Alumni/JJSS
  • Locations & Directions
  • Ways to Help
  • Disclaimer
FOLLOW US
  • Twitter Logo
  • Facebook Logo
  • Youtube Logo
  • Instagram Logo
Visit
  • New York Presbyterian Logo
  • Columbia University Irving Medical Center Logo

©1999-2026. Columbia University Irving Medical Center, Department of Surgery, New York, NY.